Hoth Therapeutics has recently made headlines with a substantial surge in its stock price, following promising data from the treatment of the first patient using its lead drug candidate, HT-001. This positive development has sparked renewed interest in the Hoth Therapeutics stock.

This article Hoth Therapeutics breakthrough! 🧬✨ Why one patient sent Hoth Therapeutics stock forecast soaring by 81% in a single day! appeared first on Guerilla Stock Trading.